SCHEMBL17945069

SCHEMBL17945069

O=Cc1cc(-c2ccccc2)c2ccccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.55
▸ KMT2A Q03164 6/20 0.55
▸ KDM4E B2RXH2 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ HPGD P15428 3/20 0.55
▸ MAPT P10636 1/20 0.55
▸ MPI P34949 1/20 0.55
▸ GPR84 Q9NQS5 2/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ RECQL P46063 1/20 0.40
▸ PTGES O14684 1/20 0.40
▸ CYP11B1 P15538 1/20 0.39
▸ CDC25B P30305 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16539622 0.82 KIF11 (0.41) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL16776534 0.82 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL30693087 0.81 ANPEP (0.42) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL6756235 0.81 ANPEP (0.42) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17950761 0.80 KDM4E (0.36) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL16548139 0.80 CYP1A1 (0.43) KDM4EALDH1A1HPGDCYP11B1POLB
SCHEMBL16548146 0.78 PPARG (0.41) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL16539732 0.77 MCL1 (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL13082255 0.76 BACE1 (0.39) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL7446125 0.75 TOP1 (0.50) KDM4EMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493396-B2 Substituted naphthalene compounds as calcium sensing receptor modulators LUPIN ATLANTIS HOLDINGS SA (CH) 2016-11-15 — — US disclosed
US-20160214924-A1 SUBSTITUTED NAPHTHALENE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN ATLANTIS HOLDINGS SA (CH) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214924-A1 SUBSTITUTED NAPHTHALENE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS CASR, RYR2, RYR1 MEN1 2646/4885KMT2A 4618/4885KDM4E 4068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback